
Y mAbs Therapeutics Inc (YMAB)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -197.636 | -35.033 | -35.463 | -44.002 | -68.503 | -32.059 | -53.979 | -15.912 |
Return on Equity (%) | -282.846 | -40.676 | -38.867 | -47.744 | -78.321 | -38.662 | -66.09 | -20.387 |
Return on Invested Capital (%) | -282.547 | -41.19 | -38.995 | -48.988 | -79.67 | -82.507 | -67.481 | -26.958 |
Operating Margin (%) | N/A | N/A | N/A | N/A | -575.118 | -158.395 | -145.328 | -24.601 |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | -575.118 | -158.395 | -146.488 | -25.262 |
Book Value Per Share | 0.729 | 3.071 | 4.11 | 5.007 | 2.601 | 4.084 | 2.433 | 2.255 |
Earnings Per Share | -1.03 | -0.716 | -1.266 | -2.04 | -2.933 | -1.265 | -2.189 | -0.491 |
Cash Per Share | 1.019 | 3.383 | 4.324 | 5.214 | 2.817 | 4.155 | 2.422 | 1.803 |
Working Capital Per Share | 0.863 | 3.119 | 4.165 | 4.993 | 2.527 | 3.991 | 2.339 | 2.086 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | 0.51 | 0.764 | 1.343 | 1.701 |
EBIT Per Share | -1.03 | -0.716 | -1.266 | -2.04 | -2.933 | -1.265 | -2.189 | -0.478 |
EBITDA Per Share | -1.03 | -0.716 | -1.266 | -2.04 | -2.933 | -1.265 | -2.189 | -0.478 |
Free Cash Flow Per Share | -1.03 | -0.716 | -1.26 | -1.994 | -2.938 | -1.261 | -2.209 | -0.508 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 16,55M | 26,75M | 34,19M | 39,73M | 40,69M | 43,7M | 43,67M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 43,67M | N/A | 43,62M | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | -31.554 | N/A | N/A | N/A | -32.457 | N/A | N/A |
Net Profit Margin (%) | N/A | -31.554 | N/A | N/A | N/A | -33.26 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 211,85M |
Ratio cours/bénéfice | -9,76 |
Ratio prix/ventes | 2,47 |
Ratio prix/liquidités | 2,66 |
Ratio prix/valeur comptable | 2,07 |
Rendement de dividende | - |
Actions en circulation | 44,79M |
Volume moyen (1 semaine) | 303,69k |
Volume moyen (1 mois) | 416,54k |
Variation sur 52 semaines | -69,28% |
Plus haut sur 52 semaines | 17,7775 |
Plus bas sur 52 semaines | 4,25 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales